Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.

Grade Last Price % Change Price Change
grade F 4.3 0.23% 0.01
CRBP closed up 0.23 percent on Thursday, November 14, 2019, on 2.01 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CRBP trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 0.23%
Calm After Storm Range Contraction 0.23%
NR7 Range Contraction 0.23%

Older signals for CRBP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Medical Specialties Organ Systems Cystic Fibrosis Channelopathies Treatment Of Cystic Fibrosis Scleroderma
Is CRBP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.11
52 Week Low 4.18
Average Volume 614,138
200-Day Moving Average 6.3754
50-Day Moving Average 5.0539
20-Day Moving Average 4.958
10-Day Moving Average 4.689
Average True Range 0.2928
ADX 24.7
+DI 12.821
-DI 25.5541
Chandelier Exit (Long, 3 ATRs ) 4.7016
Chandelier Exit (Short, 3 ATRs ) 5.0584
Upper Bollinger Band 5.7203
Lower Bollinger Band 4.1957
Percent B (%b) 0.07
BandWidth 30.750303
MACD Line -0.1959
MACD Signal Line -0.1036
MACD Histogram -0.0923
Fundamentals Value
Market Cap 215.94 Million
Num Shares 50.2 Million
EPS -0.60
Price-to-Earnings (P/E) Ratio -7.17
Price-to-Sales 125.45
Price-to-Book 9.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.56
Resistance 3 (R3) 4.54 4.45 4.51
Resistance 2 (R2) 4.45 4.38 4.45 4.50
Resistance 1 (R1) 4.37 4.34 4.41 4.39 4.48
Pivot Point 4.28 4.28 4.30 4.28 4.28
Support 1 (S1) 4.20 4.21 4.24 4.22 4.12
Support 2 (S2) 4.11 4.17 4.11 4.10
Support 3 (S3) 4.03 4.11 4.09
Support 4 (S4) 4.05